Our Laboratory
MDIP Grow Practical LabThe Heart of Our Cannabinoid Research
Our state-of-the-art MDIP Grow Practical Lab in Mecklenburg-Vorpommern combines precision cultivation with AI-driven drug discovery. The 200 m² facility features a vertical farming system with smart LED lighting (including UV/IR spectra) that optimizes production of valuable plant compounds like terpenes. A sensor-controlled irrigation system – developed with Dutch agricultural technology experts – reduces water and fertilizer use by 40%. The hermetic CO₂ circulation system (maintained at 1,200–1,500 ppm) increases biomass yield by 30%. Over 150 sensors precisely monitor temperature (22–28°C), humidity (50–70%), and light conditions.
The integrated laboratory uses HPLC to analyze cannabinoid concentrations (THC, CBD, CBG etc.) and GC-MS to identify volatile terpene compounds. Standardized extraction protocols deliver reproducible active ingredient combinations for pharmacological studies. Each growth cycle generates 15,000+ proprietary data points that train our AI-MDIP model – a key competitive advantage in discovering new therapeutic approaches. Complete data sovereignty from seedling to extract enables us to develop premium personalized cannabinoid therapies.
The Highlights
Our vertical farming infrastructure utilizes 150+ IoT sensors to monitor 27 critical growth parameters in real-time, including spectral light composition (380-780nm), CO₂ levels (maintained at 1,200-1,500 ppm), and root zone conditions. The adaptive LED arrays with tunable UV/IR components can increase target compound yields by 40-60% compared to conventional growing methods, while our Dutch-engineered irrigation system reduces water and nutrient consumption by precisely 38.7%.
The integrated laboratory operates HPLC systems capable of quantifying 12+ cannabinoids (including THC, CBD, CBG, CBN, and CBC) with ≤1% margin of error. Our GC-MS configurations identify and quantify 27 terpene compounds (including myrcene, limonene, and pinene) at detection thresholds of 0.01ppm. This analytical precision ensures batch-to-batch consistency meeting GMP standards for clinical research materials.
The facility’s hermetic design features a proprietary CO₂ recapture system that maintains optimal atmospheric conditions while reducing carbon emissions. Our data shows consistent 30.2% biomass increases compared to conventional grow operations. The integrated water purification system achieves 93% recycling efficiency, with only 7% loss through transpiration.
Each 8-week growth cycle generates 15,327 proprietary datapoints on average, feeding our AI-MDIP machine learning algorithms. This exclusive dataset captures subtle phenotype-environment correlations unavailable in public research, enabling identification of novel cannabinoid-drug synergies with 82% greater predictive accuracy than conventional models.
The modular design allows for planned 2025 expansion to 400 m² cultivation space, while the 2026 roadmap includes installation of CRISPR gene-editing workstations for targeted cannabinoid biosynthesis. Our power infrastructure already accommodates this growth, with 25% spare capacity in the 55 MWp solar array dedicated to lab operations.
"We're not just growing plants anymore; we're decoding their medicinal intelligence."
Our MDIP Grow Practical Lab represents a new paradigm in cannabinoid research, where controlled cultivation and AI-driven analysis converge to advance precision medicine.
CUTTING-EDGE CULTIVATION
The 200 m² vertical farming system employs adaptive LED spectra and IoT-controlled microenvironments to optimize plant chemistry. Sensor data correlates growth conditions with cannabinoid/terpene profiles.
INTERDISCIPLINARY RESEARCH
Botanists, data scientists, and pharmacologists collaborate to validate AI-generated hypotheses. Each growth cycle contributes 15,000+ proprietary datapoints to train our AI-MDIP platform’s predictive models.
CLOSED-LOOP SYSTEMS
A hermetic CO₂ circulation system (1,200–1,500 ppm) increases biomass by 30%, while water recycling achieves 93% efficiency. The facility operates on campus renewable energy, maintaining carbon-positive operations.
TRANSLATIONAL OUTPUTS
Standardized extracts undergo HPLC/GC-MS analysis (≤1% variance), producing research-grade materials for both therapeutic development and AI training. The modular design prepares for CRISPR integration (2026).